Prosecution Insights
Last updated: May 29, 2026

Examiner: BAUER, BRIANNA LEE

Tech Center 1600 • Art Units: 1623 1624

This examiner grants 0% of resolved cases

Performance Statistics

Allow Rate
-60.0% vs TC avg
9
Total Applications
Interview Lift
0
Avg Prosecution Days
Based on 0 resolved cases, 2023–2026

Rejection Statute Breakdown

0%
§101 Eligibility
0%
§102 Novelty
50.0%
§103 Obviousness
0%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18501136 METHOD AND COMPOSITION FOR REDUCING MYOPIA PROGRESSION Non-Final OA THE HONG KONG POLYTECHNIC UNIVERSITY
18035279 SOLID FORMULATION Non-Final OA Janssen Pharmaceuticals, Inc.
18546254 USE OF CANNABIDIVARIN IN THE TREATMENT OF SEIZURES ASSOCIATED WITH CANINE EPILEPSY Non-Final OA Jazz Pharmaceuticals Research UK Limited
18561108 OIL-IN-WATER EMULSION OF 6-ETHOXY-7-METHOXY-2-(2-METHYLSULFANYLPHENYL)-3,L-BENZOXAZIN-4-ONE Non-Final OA SIXERA PHARMA AB
18505224 COMPOSITIONS FOR TREATMENT OF SEXUAL DYSFUNCTION Non-Final OA Woody's Medical LLC
18456064 METHOD FOR APPLYING BETA-OCIMENE IN OPEN SPACE Non-Final OA Chunlin LIU

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month